| Schedule of Reportable Segment Loss, Including Significant Expenses |
The following table presents reportable segment (loss) income, including significant expenses regularly provided to the CODM, attributable to the Company’s reportable segment for the three and nine months ended September 30, 2026 and 2025 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Revenue | $ | 224,563 | | | $ | 164,859 | | | $ | 521,345 | | | $ | 361,039 | | | Less: | | | | | | | | | Cost of goods sold | 2,867 | | | 1,585 | | | 6,991 | | | 7,786 | | | Research and development: | | | | | | | | | External research and development | 38,646 | | | 27,837 | | | 97,589 | | | 77,653 | | | Internal personnel costs | 25,731 | | | 18,959 | | | 74,217 | | | 57,276 | | Other research and development | 5,927 | | | 5,094 | | | 15,874 | | | 13,212 | | | Total research and development | 70,304 | | | 51,890 | | | 187,680 | | | 148,141 | | | Selling, general and administrative | 98,414 | | | 71,046 | | | 274,779 | | | 194,041 | | | Royalty expense | 7,968 | | | 15,407 | | | 39,846 | | | 41,467 | | | In-process research and development | 113,115 | | | — | | | 113,115 | | | — | | | Total other income (expense), net | 1,173 | | | 783 | | | (37,590) | | | 2,188 | | | Income tax benefit (provision) | 5,895 | | | (8) | | | 6,220 | | | (67) | | | Income from discontinued operations, net of tax | 8,700 | | | — | | | 8,200 | | | — | | | Net (loss) income | $ | (52,337) | | | $ | 25,706 | | | $ | (124,236) | | | $ | (28,275) | |
|